CVS Facing Twin Lawsuits Over Conduct in Drug Market

Health-care entities are going “vertical,” acquiring other health-care companies in the continuum of care, and one large pharmacy chain may be engaging in anticompetitive conduct that is enabled by the deals, attorneys say.

CVS Health is facing a pair of related lawsuits in federal district courts in Florida alleging that the pharmacy chain violated antitrust laws after it got into the business of administering the 340B program—340B administrators contract with hospitals to provide software and compliance tools to administer the covered entities’ drug discount programs. The suits allege that since CVS acquired 340B administrator Wellpartner, the company has engaged in ...